British-Swedish Biopharmaceutical Company #AstraZeneca on Tuesday Stated ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, 'British-Swedish biopharmaceutical company #AstraZeneca on Tuesday stated that its monoclonal antibody treatment failed to prevent the #COVID19 symptoms in individuals already exposed to the virus.'
British-Swedish biopharmaceutical company #AstraZeneca (@AstraZeneca) on Tuesday stated that its monoclonal antibody treatment failed to prevent the #COVID19 symptoms in individuals already exposed to the virus. pic.twitter.com/VKo554Czyl— IANS Tweets (@ians_india) June 15, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jun 15, 2021 09:02 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
